← Leaderboards
Ramesh Akkina
Colorado State University-Fort Collins
$16,934,284
Attributed
$16,934,284
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,934,284 · 14
By mechanism
R01$12,675,920 · 7
P01$1,640,450 · 1
R21$1,529,183 · 4
R56$1,088,731 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoHiv-1ViralIn VitroCellsHiv InfectionsAnimal ModelVirusInfectionBaseCd4 Positive T LymphocytesT-LymphocyteMouse ModelMacrophageTransplantationHematopoietic Stem CellsIn Vivo ModelGene TherapyImmune SystemGenerationsEvaluationDendritic CellsGenesCd34 Gene
Grant awards (43)
SIV zoonosis using humanized mice$227,255
R21 · FY2025 · AI · contact PI
SIV zoonosis using humanized mice$169,880
R21 · FY2024 · AI · contact PI
A dual-purpose hu-mouse model for evaluating SIV and HIV cure strategies$643,856
R56 · FY2022 · AI · contact PI
Exploring the features of HIV exceptional elite controllers in humanized mice$193,399
R21 · FY2022 · AI · contact PI
Exploring the features of HIV exceptional elite controllers in humanized mice$244,399
R21 · FY2021 · AI · contact PI
Modeling the molecular evolution of SIV to HIV using humanized mice$478,025
R01 · FY2020 · AI · contact PI
An Ultrasensitive In Vivo Latent HIV Viral Outgrowth Assay Using Humanized Mice$683,513
R01 · FY2019 · AI · contact PI
Modeling the molecular evolution of SIV to HIV using humanized mice$477,946
R01 · FY2019 · AI · contact PI
An Ultrasensitive In Vivo Latent HIV Viral Outgrowth Assay Using Humanized Mice$683,513
R01 · FY2018 · AI · contact PI
Modeling the molecular evolution of SIV to HIV using humanized mice$480,436
R01 · FY2018 · AI · contact PI
An Ultrasensitive In Vivo Latent HIV Viral Outgrowth Assay Using Humanized Mice$683,227
R01 · FY2017 · AI · contact PI
Modeling the molecular evolution of SIV to HIV using humanized mice$477,633
R01 · FY2017 · AI · contact PI
An Ultrasensitive In Vivo Latent HIV Viral Outgrowth Assay Using Humanized Mice$662,694
R01 · FY2016 · AI · contact PI
Modeling the molecular evolution of SIV to HIV using humanized mice$498,020
R01 · FY2016 · AI · contact PI
In Vivo Model Core$368,147
P01 · FY2016 · AI · contact PI
An Ultrasensitive In Vivo Latent HIV Viral Outgrowth Assay Using Humanized Mice$662,947
R01 · FY2015 · AI · contact PI
In Vivo Model Core$340,773
P01 · FY2015 · AI · contact PI
Modeling Next Generation HIV PrEP in Humanized Mice$674,697
R01 · FY2014 · AI · contact PI
In Vivo Model Core$316,625
P01 · FY2014 · AI · contact PI
Modeling Next Generation HIV PrEP in Humanized Mice$634,144
R01 · FY2013 · AI · contact PI
In Vivo Model Core$302,501
P01 · FY2013 · AI · contact PI
Modeling Next Generation HIV PrEP in Humanized Mice$688,912
R01 · FY2012 · AI · contact PI
Efficacy Testing of HIV-Specific Microbicides in Humanized Mice$444,875
R56 · FY2012 · AI · contact PI
In Vivo Model Core$312,404
P01 · FY2012 · AI · contact PI
Humanized Rag2-/-gammac-/-mice for HIV infection and gene therapy$353,344
R01 · FY2011 · AI · contact PI
Humanized Rag2-/-gammac-/-mice for HIV infection and gene therapy$356,913
R01 · FY2010 · AI · contact PI
Humanized Rag2-/-gammac-/-mice for HIV infection and gene therapy$360,518
R01 · FY2009 · AI · contact PI
Human embryonic stem (hES) cells for hematopoietic and HIV/AIDS therapies$220,500
R21 · FY2009 · HL · contact PI
Humanized Rag2-/-gammac-/-mice for HIV infection and gene therapy$360,518
R01 · FY2008 · AI · contact PI
SiRNA Gene Therapy for HIV/AIDS$303,468
R01 · FY2008 · AI · contact PI
Human embryonic stem (hES) cells for hematopoietic and HIV/AIDS therapies$183,750
R21 · FY2008 · HL · contact PI
Humanized Rag2-/-gammac-/-mice for HIV infection and gene therapy$367,500
R01 · FY2007 · AI · contact PI
SiRNA Gene Therapy for HIV/AIDS$309,344
R01 · FY2007 · AI · contact PI
SiRNA Gene Therapy for HIV/AIDS$318,584
R01 · FY2006 · AI · contact PI
Modeling RNA-based HIV gene therapeutics in SCID-hu mice$283,185
R01 · FY2006 · AI · contact PI
SiRNA Gene Therapy for HIV/AIDS$326,250
R01 · FY2005 · AI
Modeling RNA-based HIV gene therapeutics in SCID-hu mice$290,000
R01 · FY2005 · AI
SiRNA Gene Therapy for HIV/AIDS$326,250
R01 · FY2004 · AI
Modeling RNA-based HIV gene therapeutics in SCID-hu mice$290,000
R01 · FY2004 · AI
Modeling RNA-based HIV gene therapeutics in SCID-hu mice$290,000
R01 · FY2003 · AI
Modeling RNA-based HIV gene therapeutics in SCID-hu mice$96,667
R01 · FY2002 · AI
Modeling RNA-based HIV gene therapeutics in SCID-hu mice$290,000
R21 · FY2001 · AI
HIV PATHOGENESIS AND GENE THERAPY IN SCID-HU MICE$257,672
R01 · FY2000 · AI